Scarica l'app Stockscreener
10.26
5.88%
0.57
Dopo l'orario di chiusura:
10.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$9.69
Aprire:
$9.6
Volume 24 ore:
918.96K
Relative Volume:
1.53
Capitalizzazione di mercato:
$592.02M
Reddito:
$1.12B
Utile/perdita netta:
$55.30M
Rapporto P/E:
10.80
EPS:
0.95
Flusso di cassa netto:
$-30.30M
1 W Prestazione:
+0.39%
1M Prestazione:
-2.56%
6M Prestazione:
-50.31%
1 anno Prestazione:
-15.56%
Intervallo 1D:
$9.56
$10.38
Intervallo di 1 settimana:
$9.20
$10.38
Portata 52W:
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
Nome
Embecta Corp
Settore
Industria
Telefono
(862) 401-0000
Indirizzo
1209 ORANGE STREET, WILMINGTON
Confronta EMBC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
10.26 | 592.02M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | Wolfe Research | Peer Perform |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | Iniziato | BTIG Research | Neutral |
| 2022-08-01 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-06-21 | Iniziato | BofA Securities | Underperform |
Mostra tutto
Embecta Corp Borsa (EMBC) Ultime notizie
Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction - MSN
Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Transcript : Embecta Corp. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
InvestingPro’s bearish call on Embecta proves accurate with 48% decline By Investing.com - Investing.com Nigeria
Embecta stock hits 52-week low at $10.26 amid market challenges By Investing.com - Investing.com South Africa
Embecta stock hits 52-week low at $10.26 amid market challenges - Investing.com Australia
BofA cuts Embecta stock price target to $18 from $20 By Investing.com - Investing.com South Africa
BofA cuts Embecta stock price target to $18 from $20 - Investing.com India
(EMBC) Technical Data - news.stocktradersdaily.com
Embecta Corp (EMBC) Stock Price Down 6.22% on May 28 - GuruFocus
embecta to Participate in Investor Events - The Manila Times
embecta to Participate in Investor Events - GlobeNewswire Inc.
Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock - Yahoo Finance
Insider Buying: David Melcher Acquires 10,000 Shares of Embecta Corp (EMBC) - GuruFocus
Director Makes Bold Move with Major Stock Purchase in Embecta Corporation! - TipRanks
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | - GuruFocus
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | EMBC Stock News - GuruFocus
Embecta (EMBC) Price Target Cut by Mizuho Amid Flat Sales Outlook | EMBC Stock News - GuruFocus
Embecta price target lowered to $25 from $26 at BTIG - TipRanks
Embecta Corporation’s Strategic Transition and Financial Outlook: A Buy Rating Based on Growth Initiatives and Attractive Valuation - TipRanks
Embecta Corp (EMBC) Shares Gap Down to $10.85 on May 22 - GuruFocus
Embecta stock touches 52-week low at $10.82 amid market challenges - Investing.com Australia
Embecta eyes shift from insulin delivery to broader medical supplies focus - Drug Delivery Business
Transcript : Embecta Corp.Analyst/Investor Day - marketscreener.com
Embecta stock touches 52-week low at $10.82 amid market challenges By Investing.com - Investing.com South Africa
Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15 - simplywall.st
Embecta Unveils Strategy at Analyst and Investor Day - TipRanks
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 - Yahoo Finance
Embecta Corp. Re-Affirms Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - The Manila Times
Embecta Corp. Hosts Inaugural Analyst and Investor Day to Outline Long-Term Financial Plan and Strategic Priorities - Nasdaq
embecta to Showcase Phased Approach for Value Creation and - GlobeNewswire
embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.
Cautious Outlook on Embecta Corporation Amidst Unclear Growth Catalysts and Margin Concerns - TipRanks
Embecta Corp (EMBC) Shares Down 2.83% on May 19 - GuruFocus
How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com
Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - MSN
Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply (NASDAQ:EMBC) - Seeking Alpha
Embecta restructures again, outlines tariff costs - MedTech Dive
Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating - marketscreener.com
Positive Outlook for Embecta Corporation Amid Strong Financial Performance and Strategic Initiatives - TipRanks
Cautious Optimism for Embecta Corporation Amid Challenging Environment and Hold Rating - TipRanks
Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com
Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com Nigeria
Embecta Corp Azioni (EMBC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Embecta Corp Azioni (EMBC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):